Congruence starts human trials for first drug, raises $40M
Congruence starts human trials for first drug, raises $40M
Body unavailable. Use the original source.
Congruence starts human trials for first drug, raises $40M
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.